Search Within


Filtros aplicados
Palabra clave:'200-675-3'
Mostrando 1-2 of 2 resultados para "200-675-3" en el plazo de Papeles
S Mallal et al.
Lancet (London, England), 359(9308), 727-732 (2002-03-13)
The use of abacavir--a potent HIV-1 nucleoside-analogue reverse-transcriptase inhibitor--is complicated by a potentially life-threatening hypersensitivity syndrome in about 5% of cases. Genetic factors influencing the immune response to abacavir might confer susceptibility. We aimed to find associations between MHC alleles
Paul K Drain et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(10), 2143-2151 (2019-07-18)
Direct measurement of tenofovir (TFV) in urine could be an objective measure to monitor adherence to preexposure prophylaxis (PrEP) or TFV-based antiretroviral therapy (ART). We conducted a 3-arm randomized, pharmacokinetic study of tenofovir disoproxil fumarate (TDF) 300 mg/emtricitabine (FTC) 200
Página 1 de 1
Página 1 de 1